Search

everythinglearnresearchcommunity

for

Search:↓

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

A new mutation in the HR gene causes hair loss in a specific family.

A Turkish family with sparse hair and eyebrow loss has a mutation in the U2HR gene linked to Marie Unna hereditary hypotrichosis.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Testosterone is crucial for development, growth, and various body functions in mammals.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Gene mutations can cause problems in male genital development.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.